Francesca Polverino
Professor
Positions
- Professor
-
Medicine - Pulmonary
91¹ú²úÊÓƵ
Houston, Texas, United States
- Lester and Sue Smith Associate Professor
-
Medicine - Pulmonary
91¹ú²úÊÓƵ
Houston, US
- Assistant Professor
-
Medicine
Pulmonary and Critical Care
Harvard Medical School
Boston
- Instructor
-
Medicine
Pulmonary and Critical Care
Harvard Medical School
Boston
- Associate Professor
-
Medicine
Asthma and Airway Disease research center
University of Arizona
Tucson
- Lester and Sue Smith Full Professor
-
Medicine
91¹ú²úÊÓƵ
Houston
- Professor
-
Obstetrics and Gynecology
91¹ú²úÊÓƵ
Addresses
- Polverino Laboratory (Office)
-
6501 Fannin St
Methodist Neurosensory Center of Houston
Houston, TX, 77030
United States
Phone: (617) 306-8999
Education
- MD from University of Naples
- 06/2006 - Naples, Italy
- PharmD from University of Parma
- 03/2017 - Parma, Italy
- Residency at University of Messina
- 07/2011 - Messina, Italy
- Postdoctoral Fellowship at Harvard Medical School
- 10/2011 - Boston, United States
- Fellowship at University of Padua
- 10/2007 - Padua, Italy
- Fellowship at Hospital Son Dureta
- 03/2007 - Palma de Mallorca, Spain
Certifications
- Texas Medical Board License
- Texas Medical Board
- Italian Medical Board License
- Italian Medical Board
Honors & Awards
- Rising Star of Research
- American Thoracic Society (05/2017)
- Outstanding Italian Scientist
- Presidency of Italian Republic (06/2019)
- COPD Gold Medal
- European Respiratory Society (09/2022)
- Parker B Francis Award
- American Thoracic Society (05/2023)
- Fellow of the American Thoracic Society (ATSF)
- (01/2024)
- Oustanding Woman in Pulmonary Medicine
- Brazilian Respiratory Society (10/2024)
Professional Statement
Francesca Polverino’s research focuses on understanding the pathobiology underlying chronic obstructive pulmonary disease (COPD). COPD is the third leading cause of death both in the USA and globally. COPD has a multifactorial nature, being determined not only by environmental, but also genetic, genomic, and developmental factors, which accounts for an individual susceptibility to develop the disease. In the era of precision medicine, our ultimate goal is to understand key factors in the pathogenesis of COPD to be targeted in a selected subset of COPD patients.
Websites
International COPD research group
Videos
Professional Development
- Co-director of BCM Pulmonary Grand Rounds
- Seminar (Organizer)
Memberships
- American Thoracic Society
- Executive Committee Member, Respiratory Cell and Molecular Biology (RCMB) Assembly
- European Respiratory Society
- College of Experts Member
Funding
-
B cell-adaptive Immune Profile in Emphysema-predominant COPD
#R01HL149744 - Grant funding from NIH/NHLBI
-
COPD GOLD Medal
- Unrestricted funding from European Respiratory Society- Boehringer Ingelheim
-
Unrestricted funds for lung cancer studies
- (05/10/2023)
- VICTORY Houston
-
Detrimental Effects of B cell-Th17 Axis in Antiviral Immunity in Smokers
#R01HL177930 - NHLBI
-
Protective role of metformin against AT2 cell fatty acid dysmetabolism
#R01HL171622 - NHLBI
-
Therapeutic Potential of Targeting Dkk1 in COPD
#Pathway Award - Sanofi-Regeneron
-
B cell adaptive immune profile in A1AT deficiency-associated emphysema
#Alpha 1 Foundation Research Grant - Alpha 1 Foundation
Skills
- Lung pathology
- Lung transcriptomics/ spatial transcriptomics
- Lung immunity
- Microscopy
- Adaptive immunity
- COPD management
- Asthma management
Languages
Spanish, Italian
to edit your profile